Crackdown On Substandard Ayurvedic Medicines

THIRUVANANTHAPURAM: Various batches of ayurvedic medicines of Rajasthan Herbal International Pvt Ltd have been found to be of substandard quality during quality tests conducted at the drug testing laboratories of the State Drugs Controller’s Department. Following this, the Ayurvedic Drugs Control Department banned the distribution and sale of these medicines.

 

Traders and hospitals holding stock of drugs should return the same to the distributor and inform the District Ayurvedic Drugs Inspectors concerned, the officials said. Name and batch number of medicines are: Pain Niwaran Churna (PNF21057), Dr Relaxi Capsule (DRG21019), Pain Niwaran Churna (PNK21089), Mood on Forever (MCE21003), Dr Relaxi Capsule (DRK21030), Dr Relaxi Oil (DOD21004), Dama Buti Churna (DBH21017), Asthalex Capsule (ALK21004).

Related Posts

Piyush Goyal meets pharma industry leaders to discuss R&D, competitiveness boost

New Delhi: Union Commerce and Industry Minister Piyush Goyal has discussed strategies to boost competitiveness and strengthen research and development activities with the business representatives of the pharmaceutical industry. “Had…

Senores Pharma to Buy Two Teva ANDAs

Mumbai, August 14, 2025 — Senores Pharmaceuticals will acquire two abbreviated new drug applications (ANDAs) from Teva Pharmaceuticals USA. The deal is Senores’ third US move in six months, underscoring…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Piyush Goyal meets pharma industry leaders to discuss R&D, competitiveness boost

Piyush Goyal meets pharma industry leaders to discuss R&D, competitiveness boost

Senores Pharma to Buy Two Teva ANDAs

Senores Pharma to Buy Two Teva ANDAs

Lab-grown rabies antibodies show promise as cheaper, safer alternative

Lab-grown rabies antibodies show promise as cheaper, safer alternative

Lilly launches Mounjaro KwikPen in India

Lilly launches Mounjaro KwikPen in India